Profile data is unavailable for this security.
About the company
Amrutanjan Health Care Limited is an India-based company, which is engaged in the business of manufacturing, supplying and sale of products in pain management, congestion management, beverages, and hygiene and services in pain management. Its segments include OTC Products, Women Hygiene, Beverages and Others. The OTC Products segment is engaged in manufacturing products for pain management, congestion management and hygiene. The Women Hygiene includes Comfy Snug Fit, Comfy Snug Fit Extra Long, and Comfy Snug Fit Ultra XL. The Beverages segment is engaged in manufacturing fruit juices and oral hydration drinks. The Others segment includes the pain management center. The Company’s pain management products include Pain Balm Extra Power, Strong Pain Balm, New Maha Strong Pain Balm, Roll on and Advanced Back Pain + Roll-On, among others. Its congestion management products include Relief Cold Rub, Relief Nasal Inhaler, Relief Cough Syrup and Relief Swas Mint.
- Revenue in INR (TTM)4.88bn
- Net income in INR569.03m
- Incorporated1936
- Employees631.00
- LocationAmrutanjan Health Care LtdNEW NO.103, OLD NO. 42-45LUZ CHURCH ROADMYLAPORECHENNAI 600004IndiaIND
- Phone+91 4 424994465
- Fax+91 4 424994585
- Websitehttps://www.amrutanjan.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lincoln Pharmaceuticals Ltd | 6.52bn | 878.34m | 13.11bn | 1.85k | 14.92 | -- | 12.86 | 2.01 | 43.86 | 43.86 | 325.55 | -- | -- | -- | -- | 3,518,272.00 | -- | 13.22 | -- | 15.46 | 53.64 | 50.82 | 13.47 | 14.56 | -- | 77.35 | -- | 3.32 | 7.35 | 10.03 | -11.74 | 9.87 | 20.13 | -- |
| Syncom Formulations (India) Ltd | 5.15bn | 630.52m | 13.14bn | 554.00 | 20.26 | 3.47 | 19.23 | 2.55 | 0.69 | 0.69 | 5.56 | 4.03 | 1.24 | 8.89 | 5.41 | 9,296,547.00 | 15.22 | 8.56 | 17.65 | 11.58 | 36.52 | 34.81 | 12.24 | 10.15 | 4.24 | 73.92 | 0.0018 | -- | 76.55 | 17.74 | 95.28 | 28.24 | 41.62 | -- |
| Hester Biosciences Ltd | 3.14bn | 409.47m | 13.31bn | 562.00 | 41.52 | -- | 22.32 | 4.23 | 37.69 | 37.69 | 277.25 | -- | -- | -- | -- | 5,594,555.00 | -- | 5.39 | -- | 6.72 | 73.52 | 64.87 | 13.51 | 11.44 | -- | 9.65 | -- | 23.77 | 2.15 | 11.16 | 45.52 | -1.18 | -22.47 | 1.18 |
| Beta Drugs Ltd | 3.86bn | 464.68m | 13.87bn | 399.00 | 19.70 | 6.27 | 22.64 | 3.60 | 69.72 | 65.19 | 509.33 | 218.94 | 0.986 | 3.64 | 3.48 | 9,665,303.00 | 11.88 | 15.08 | 16.29 | 21.53 | 39.79 | 40.30 | 12.05 | 12.72 | 2.45 | 5.13 | 0.3974 | 0.00 | 22.54 | 31.89 | 28.96 | 37.92 | 19.23 | -- |
| Ngl Fine Chem Ltd | 4.47bn | 353.73m | 14.07bn | 456.00 | 39.77 | -- | 26.43 | 3.15 | 57.26 | 57.26 | 723.35 | -- | -- | -- | -- | 9,799,871.00 | -- | 13.34 | -- | 17.44 | 51.62 | 41.63 | 7.92 | 12.15 | -- | 9.06 | -- | 2.85 | 8.73 | 19.41 | -48.87 | 20.44 | 53.91 | 0.00 |
| Windlas Biotech Ltd | 8.68bn | 667.47m | 16.97bn | 1.35k | 25.59 | -- | 17.34 | 1.95 | 31.46 | 31.46 | 409.16 | -- | -- | -- | -- | 6,450,929.00 | -- | 8.65 | -- | 11.81 | 38.34 | 34.09 | 7.69 | 7.70 | -- | 15.80 | -- | 18.33 | 20.43 | 18.24 | 4.82 | 30.34 | 27.99 | -- |
| Amrutanjan Health Care Ltd | 4.88bn | 569.03m | 18.38bn | 631.00 | 32.31 | -- | 29.07 | 3.76 | 19.68 | 19.68 | 168.85 | -- | -- | -- | -- | 7,736,897.00 | -- | 15.84 | -- | 19.67 | 50.87 | 52.17 | 11.66 | 13.26 | -- | 319.69 | -- | 19.82 | 7.26 | 11.56 | 13.03 | 15.17 | 69.46 | 26.76 |
| Indoco Remedies Ltd | 17.58bn | -1.14bn | 18.67bn | 6.05k | -- | -- | 292.20 | 1.06 | -12.52 | -12.52 | 197.86 | -- | -- | -- | -- | 2,905,519.00 | -- | 4.84 | -- | 6.87 | 71.18 | 65.70 | -6.62 | 5.16 | -- | -0.3334 | -- | 17.11 | -8.38 | 8.51 | -174.89 | -- | 43.53 | -7.79 |
| Morepen Laboratories Ltd | 17.87bn | 994.48m | 21.12bn | 1.81k | 21.24 | -- | 14.33 | 1.18 | 1.81 | 1.81 | 32.65 | -- | -- | -- | -- | 9,850,214.00 | -- | 8.14 | -- | 12.81 | 33.71 | 31.83 | 5.61 | 5.91 | -- | 5.59 | -- | -- | 7.17 | 16.26 | 22.73 | 28.58 | 65.86 | -- |
| Panacea Biotec Ltd | 6.04bn | -72.40m | 21.44bn | 1.29k | -- | 2.59 | 81.72 | 3.55 | -1.18 | -1.18 | 98.44 | 134.92 | 0.4836 | 1.38 | 8.67 | 4,681,039.00 | -0.6085 | 13.08 | -0.8291 | 19.61 | 58.47 | 48.06 | -1.26 | 30.99 | 0.9785 | -14.33 | 0.0271 | 0.00 | -0.0132 | 0.5466 | -613.56 | -- | 48.74 | -- |
| IOL Chemicals and Pharmaceuticals Ltd | 16.47bn | 953.20m | 21.94bn | 2.89k | 23.00 | -- | 14.27 | 1.33 | 3.25 | 3.25 | -- | -- | -- | -- | -- | 5,696,991.00 | -- | 10.26 | -- | 13.42 | 34.43 | 32.57 | 5.79 | 9.33 | -- | 8.05 | -- | 13.68 | -2.51 | 1.88 | -24.82 | -22.49 | 21.61 | 5.92 |
| Solara Active Pharma Sciences Ltd | 12.55bn | -191.10m | 22.08bn | 1.78k | -- | -- | 28.01 | 1.76 | -4.81 | -4.81 | 330.32 | -- | -- | -- | -- | 7,068,733.00 | -- | -3.27 | -- | -5.35 | 51.77 | 39.95 | -1.52 | -6.17 | -- | 0.7946 | -- | -- | -0.4003 | -0.5816 | 100.10 | -65.75 | -31.71 | -- |
| Bliss GVS Pharma Ltd | 8.68bn | 1.09bn | 23.04bn | 966.00 | 21.39 | -- | 15.65 | 2.65 | 10.18 | 10.18 | 80.97 | -- | -- | -- | -- | 8,986,598.00 | -- | 6.04 | -- | 7.54 | 52.65 | 46.33 | 13.18 | 9.45 | -- | 8.44 | -- | 8.27 | 5.13 | 3.27 | 11.72 | -2.82 | 5.18 | 0.00 |
Data as of Feb 13 2026. Currency figures normalised to Amrutanjan Health Care Ltd's reporting currency: Indian Rupee INR
8.54%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| DSP Asset Managers Pvt. Ltd.as of 31 Jan 2026 | 1.47m | 5.02% |
| ICICI Prudential Asset Management Co. Ltd. (Invt Mgmt)as of 31 Jan 2026 | 715.72k | 2.45% |
| Alquity Investment Management Ltd.as of 12 Feb 2026 | 116.09k | 0.40% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 103.95k | 0.36% |
| Matthews International Capital Management LLCas of 06 Feb 2026 | 56.52k | 0.19% |
| SSgA Funds Management, Inc.as of 05 Feb 2026 | 29.88k | 0.10% |
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 3.41k | 0.01% |
| American Century Investment Management, Inc.as of 05 Feb 2026 | 2.92k | 0.01% |
| DFA Australia Ltd.as of 30 Nov 2025 | 315.00 | 0.00% |
More ▼
Data from 31 Dec 2025 - 12 Feb 2026Source: FactSet Research Systems Inc.
